Graded review
VO2 Max and Longevity: The Strongest Fitness Predictor of Lifespan
Cardiorespiratory fitness is one of the best-validated predictors of mortality — low fitness carries risk on par with smoking, and it's trainable.
Evidence scorecard
Top of the scorecard
Grade A
CoreAge Rx
Doctor-reviewed longevity peptides and NAD+ with one published per-protocol price and built-in human support.
$93–$99/mo (12-mo plan)
Check availability- Pricing
- Flat monthly, no membership
- Pharmacy
- 503A compounding pharmacy
- Labs
- No labs required
- Consult
- Clinician review included
- Support
- 1:1 nurse + dietitian
Advertising disclosure — we may earn a commission at no extra cost to you. Affiliate partners are listed first on the scorecard.
Also on the scorecard
Grade C
Try Ageless
Every advertised longevity price is an intro-code rate, and the site says outright the real figure arrives after review.
$176–$249/mo list
Visit Try AgelessEvery advertised longevity price is a limited-time intro-code rate: the real list prices are $249 (NAD+ injection) and $176 (sermorelin injection), not the $199 and $126 shown. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.
Of all the numbers people chase in the name of living longer, VO2 max has the strongest claim to actually matter. It is the single best-validated fitness predictor of how long you'll live — not a supplement, not a clock, not a clinic protocol, but a measure of how much oxygen your body can use at maximal effort. The evidence behind it is unusually deep and consistent: large prospective cohorts, a formal American Heart Association statement, and a clean dose-response gradient where more fitness means lower death rates. Crucially, unlike your age or your genes, it is something you can change. Here is what the science actually shows, graded honestly.
What VO2 max is
VO2 max (maximal oxygen uptake) is the highest rate at which your body can take in, transport, and use oxygen during all-out exercise, expressed in milliliters of oxygen per kilogram of body weight per minute (mL/kg/min). It is the gold-standard measure of cardiorespiratory fitness (CRF) — the integrated capacity of your lungs, heart, blood, and muscles to deliver and consume oxygen. A higher number means a more capable engine.
The textbook measurement is a graded exercise test on a treadmill or bike with a mask analyzing your expired air. In research and clinical practice, fitness is also commonly estimated from how long and how hard someone can sustain a treadmill protocol, expressed in metabolic equivalents (METs), where 1 MET is resting metabolism and higher peak METs mean higher fitness. Wearables now estimate VO2 max from heart-rate-to-pace relationships; those estimates are useful for tracking trends but are not as accurate as a lab test.
Why it predicts mortality so well
This is where VO2 max separates itself from almost every other longevity marker: the evidence is both large and old, which is exactly what you want.
The landmark modern study analyzed 122,007 adults who underwent treadmill exercise testing and were followed for a median of 8.4 years. The relationship between fitness and survival was strikingly graded: the least-fit participants had dramatically higher all-cause mortality, and there was no observed upper limit to the benefit — the very fittest (elite performers) had the lowest mortality of all1. The authors framed the size of the effect bluntly: the risk associated with the lowest fitness was comparable to or greater than traditional clinical risk factors such as smoking, diabetes, and hypertension1.
Strength of evidence
- ALow fitness predicts higher mortalityStrong evidence
122,007-adult cohort + 2009 meta-analysis + 1989 cohort; risk on par with smoking/diabetes.
- AVO2 max is improvable with trainingStrong evidence
Interval and continuous aerobic training both raise CRF in middle-aged and older adults.
- BRaising YOUR VO2 max extends YOUR lifeModerate evidence
Strong association, but observational — no randomized lifespan trial; causation not proven.
That finding sits on a deep foundation. In a classic study of men referred for exercise testing, peak exercise capacity was a more powerful predictor of death than established cardiovascular risk factors, and each 1-MET increase in capacity conferred roughly a 12% improvement in survival2. A 2009 meta-analysis pooling healthy men and women confirmed the gradient across populations: higher CRF predicted substantially lower all-cause mortality and fewer cardiovascular events, with low fitness carrying a markedly elevated risk3. And the foundational 1989 cohort from the Aerobics Center showed the same pattern decades earlier — higher physical fitness predicted lower all-cause mortality in both men and women, with the steepest benefit gained moving from the least-fit group to merely moderately fit4.
The convergence of these studies — across eras, populations, and methods — is why the American Heart Association issued a 2016 scientific statement arguing that CRF should be treated as a clinical vital sign, measured and tracked like blood pressure, because it adds prognostic information beyond standard risk factors5. Very few longevity interventions earn that kind of institutional backing. (For how this fits the broader, honestly-graded landscape, see our pillar on the evidence behind longevity medicine.)
The honest caveats
None of this means VO2 max is a magic number, and honest framing matters here. First, almost all of this evidence is observational — these are associations, not randomized proof that raising your VO2 max causes you to live longer. People who are fitter differ in many ways (they tend to be leaner, less likely to smoke, more affluent, healthier at baseline), and statistical adjustment is imperfect. The biological case is strong and the dose-response is clean, but the formal causal claim — "improve your fitness, extend your life" — has not been proven by a randomized lifespan trial, because such a trial is essentially impossible to run.
Second, this is a healthspan and mortality-risk marker, not a guarantee of extra years for any one person. A high VO2 max strongly tilts the population odds in your favor; it does not exempt an individual from cancer, accidents, or bad genetics.
Third, the number is relative to your age and sex. A VO2 max of 35 mL/kg/min is poor for a 25-year-old man but excellent for a 70-year-old woman. Reference standards from the large FRIEND registry of cardiopulmonary exercise tests exist precisely so that a measured value can be placed into an age- and sex-specific percentile rather than judged against a single threshold6. What matters for risk is where you fall in your own demographic band, and which direction you're trending.
The genuinely good news: it's trainable
Here is what elevates VO2 max from interesting to actionable. Unlike a DNA-methylation clock or your chronological age, cardiorespiratory fitness responds to training at essentially any age — and the biggest risk reduction in every cohort comes from leaving the bottom fitness category, which is the most achievable improvement there is4.
Both moderate continuous aerobic exercise (the classic "Zone 2" steady-state work) and higher-intensity interval training raise VO2 max. A 2021 systematic review and meta-analysis in middle-aged and older adults found that interval training and moderate-intensity continuous training both improved cardiorespiratory fitness, with interval training producing somewhat larger VO2 max gains in this population7. The practical synthesis most exercise physiologists land on is a base of frequent easy-to-moderate aerobic work to build volume, plus a smaller dose of harder intervals to push the ceiling — but the dominant message from the mortality data is simpler: any move up from the least-fit category is where the largest survival benefit lives14.
The dose-response chain
Aerobic training
Zone 2 base + intervals
Higher VO2 max
Move up your age/sex percentile
Lower mortality risk
Biggest gain: leaving the least-fit band (association)
VO2 max also belongs to the same family of cheap, functional measures that predict survival — grip strength, gait speed, and the chair-stand among them — that a 2010 BMJ meta-analysis tied to mortality across community-dwelling adults8. It is the cardiovascular member of that family, and arguably the best-studied. (Its muscular counterpart is covered in our look at grip strength as a longevity biomarker, and the floor-mobility version in the sitting-rising test and longevity.)
How to actually measure yours
You have three tiers of options. A laboratory or clinical cardiopulmonary exercise test (CPET) with a mask is the accurate gold standard and the one used in the research above; it is also the most expensive and least convenient. A submaximal field test (a timed run, a step test, or a treadmill protocol scored in METs) gives a reasonable estimate. And a wearable that estimates VO2 max from heart rate and pace is the least accurate but the easiest to repeat — best used to watch your own trend over months rather than to pin down an exact value.
For most people the useful workflow is: get one decent baseline (lab if you can, a validated field test if not), place it in an age- and sex-specific percentile using FRIEND-style reference standards6, and then train to move up a band — re-testing every few months. If you're building a broader assessment, this pairs naturally with the lab side of the picture in our guide to longevity biomarker panels.
Where this fits in evidence-based longevity
Among the things marketed under the longevity banner, cardiorespiratory fitness stands out for having the rare combination the others lack: a huge, consistent, decades-deep evidence base; an effect size on par with major clinical risk factors; institutional endorsement as a vital sign; and — best of all — genuine modifiability at any age. It earns an honest high grade not because of hype but because the data keep saying the same thing. Notably, in the Finnish cohort data, fitness and frequent sauna use were additive — the lowest mortality belonged to men who were both fit and regular sauna-goers — which is why we treat the sauna's longevity case as a complement to fitness, not a substitute. If you want to see how the clinics and programs that build structured fitness and assessment into longevity care actually compare on evidence, oversight, and price, we grade the field in our best longevity clinics hub.
The bottom line
VO2 max is, on the current evidence, the strongest fitness-based predictor of longevity we have. Low cardiorespiratory fitness carries mortality risk comparable to smoking or diabetes, and the relationship is graded with no clear ceiling — fitter is better, all the way up. The honest caveat is that the evidence is observational, so it proves strong association rather than guaranteed causation, and your number must be read against your own age and sex. But the practical takeaway is unusually clean: this is a high-impact marker you can actually move, the biggest gains come from leaving the least-fit group, and a mix of easy aerobic volume and harder intervals is how you do it.
Frequently asked questions
Is VO2 max really the best predictor of longevity?
Among fitness measures, it has the strongest and most consistent evidence. In a 122,007-adult study, low cardiorespiratory fitness carried mortality risk comparable to or greater than smoking, diabetes, and hypertension, with a graded benefit and no observed upper limit. The American Heart Association recommends treating fitness as a clinical vital sign. The main caveat: this evidence is observational, so it shows strong association rather than proven causation.
What's a good VO2 max for my age?
It depends heavily on age and sex — a value that's poor for a 25-year-old can be excellent for a 70-year-old. Rather than chase a single number, place your measured VO2 max into an age- and sex-specific percentile using reference standards like the FRIEND registry, and focus on which direction you're trending.
Can you actually improve your VO2 max?
Yes, at essentially any age — that's what makes it actionable. A 2021 meta-analysis in middle-aged and older adults found both interval training and moderate-intensity continuous aerobic exercise raised VO2 max. The largest mortality benefit in every cohort comes from leaving the least-fit category, which is also the most achievable improvement.
How do you measure VO2 max accurately?
The gold standard is a lab cardiopulmonary exercise test (CPET) with a mask analyzing your breath. Submaximal field tests and treadmill protocols scored in METs give reasonable estimates. Wearables estimate it from heart rate and pace — least accurate, but easy to repeat for tracking your trend over months.
References
- Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing.. JAMA Network Open. https://pubmed.ncbi.nlm.nih.gov/30646252/
- Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002). Exercise capacity and mortality among men referred for exercise testing.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/11893790/
- Kodama S, Saito K, Tanaka S, et al. (2009). Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.. JAMA. https://pubmed.ncbi.nlm.nih.gov/19454641/
- Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW (1989). Physical fitness and all-cause mortality. A prospective study of healthy men and women.. JAMA. https://pubmed.ncbi.nlm.nih.gov/2795824/
- Ross R, Blair SN, Arena R, et al. (American Heart Association) (2016). Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association.. Circulation. https://pubmed.ncbi.nlm.nih.gov/27881567/
- Kaminsky LA, Arena R, Myers J, et al. (2022). Updated Reference Standards for Cardiorespiratory Fitness Measured with Cardiopulmonary Exercise Testing: Data from the Fitness Registry and the Importance of Exercise National Database (FRIEND).. Mayo Clinic Proceedings. https://pubmed.ncbi.nlm.nih.gov/34809986/
- Poon ET, Little JP, Sit CH, Wong SH (2021). Interval training versus moderate-intensity continuous training for cardiorespiratory fitness improvements in middle-aged and older adults: a systematic review and meta-analysis.. Journal of Sports Sciences. https://pubmed.ncbi.nlm.nih.gov/33825615/
- Cooper R, Kuh D, Hardy R; Mortality Review Group (2010). Objectively measured physical capability levels and mortality: systematic review and meta-analysis.. BMJ. https://pubmed.ncbi.nlm.nih.gov/20829298/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
GLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadCreatine for Aging: The Cheapest Evidence-Backed Supplement?
Creatine has the strongest human evidence of any longevity supplement — for healthspan, not lifespan. With resistance training it adds muscle and strength.
ReadCoQ10 & Ubiquinol for Aging: What the Evidence Actually Shows
KiSel-10 showed CoQ10 plus selenium cut cardiovascular mortality in elderly Swedes — but the benefit is CV-specific, not lifespan. An honest grade.
ReadBest Epigenetic Clock: GrimAge vs PhenoAge vs DunedinPACE
GrimAge predicts mortality, PhenoAge predicts disease, DunedinPACE measures pace of aging. No clock is validated to guide your treatment. An honest comparison.
ReadZone 2 Training for Longevity: The Evidence, Graded Honestly
Zone 2 has a strong mitochondrial mechanism and builds the fitness that predicts lifespan — but no trial proves Zone 2 itself extends life. Graded honestly.
ReadAcarbose for Longevity: The Strongest Mouse Drug You've Never Heard Of
Acarbose robustly extended mouse lifespan in the NIA's rigorous ITP — better replicated than most longevity drugs. But there are zero human longevity trials.
Read